Presentation is loading. Please wait.

Presentation is loading. Please wait.

Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern.

Published byMillicent Snow Modified over 7 years ago

Similar presentations

Presentation on theme: "Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern."— Presentation transcript:

1 Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern Med. 2013;159(11):758-769. doi:10.7326/0003-4819-159-11-201312030-00008 Summary of evidence search and selection. BMI = body mass index. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

2 Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern Med. 2013;159(11):758-769. doi:10.7326/0003-4819-159-11-201312030-00008 Prevalence of metabolically healthy and unhealthy individuals in normal-weight, overweight, and obese groups. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

3 Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern Med. 2013;159(11):758-769. doi:10.7326/0003-4819-159-11-201312030-00008 Meta-analyses of metabolically healthy body mass index categories for the risk for all-cause mortality and cardiovascular events compared with metabolically healthy normal-weight persons (reference). A. Metabolically healthy overweight group. B. Metabolically healthy overweight group, including only studies with at least 10 y of follow-up. C. Metabolically healthy obese group. D. Metabolically healthy obese group, including only studies with at least 10 y of follow-up. CV = cardiovascular. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

4 Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern Med. 2013;159(11):758-769. doi:10.7326/0003-4819-159-11-201312030-00008 Meta-analyses of metabolically unhealthy body mass index categories for the risk for all-cause mortality and cardiovascular events compared with metabolically healthy normal-weight persons (reference). A. Metabolically unhealthy normal-weight group. B. Metabolically unhealthy overweight group. C. Metabolically unhealthy obese group. CV = cardiovascular. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

5 Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern Med. 2013;159(11):758-769. doi:10.7326/0003-4819-159-11-201312030-00008 Meta-analyses of unhealthy normal-weight phenotype for the risk for all-cause mortality and cardiovascular events compared with metabolically unhealthy obese (A) and metabolically unhealthy overweight (B) persons. CV = cardiovascular. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

6 Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern Med. 2013;159(11):758-769. doi:10.7326/0003-4819-159-11-201312030-00008 Meta-analyses of various clinical characteristics, by metabolic–body mass index categories. Data shown as weighted mean difference compared with metabolically healthy normal-weight persons (reference). To convert cholesterol, triglyceride, and glucose values to traditional units (mg/dL), divide by 0.0259, 0.0113, and 0.0555, respectively. HOMA-IR = Homeostasis Model Assessment of Insulin Resistance.* P < 0.05. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Download ppt "Date of download: 6/2/2016 From: Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta- analysis Ann Intern."

Similar presentations

The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.

The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & Early DM (Part 1) Stan Schwartz MD, FACP, FACE.

The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & Early DM (Part 1) Stan Schwartz MD, FACP, FACE.
Date of download: 5/29/2016 From: Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes Ann Intern Med.

Date of download: 5/29/2016 From: Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes Ann Intern Med.
Date of download: 5/29/2016 From: Statins and Cognitive Function: A Systematic Review Ann Intern Med. 2013;159(10):688-697. doi:10.7326/0003-4819-159-10-201311190-00007.

Date of download: 5/29/2016 From: Statins and Cognitive Function: A Systematic Review Ann Intern Med. 2013;159(10): doi: /
Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.

Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.
Date of download: 5/31/2016 From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation.

Date of download: 5/31/2016 From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation.
Date of download: 5/31/2016 From: Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring.

Date of download: 5/31/2016 From: Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring.
Date of download: 5/31/2016 From: Polymorphonuclear Leukocytes in Non-Insulin-dependent Diabetes Mellitus: Abnormalities in Metabolism and Function Ann.

Date of download: 5/31/2016 From: Polymorphonuclear Leukocytes in Non-Insulin-dependent Diabetes Mellitus: Abnormalities in Metabolism and Function Ann.
Date of download: 6/2/2016 From: Quantitative Synthesis in Systematic Reviews Ann Intern Med. 1997;127(9):820-826. doi:10.7326/0003-4819-127-9-199711010-00008.

Date of download: 6/2/2016 From: Quantitative Synthesis in Systematic Reviews Ann Intern Med. 1997;127(9): doi: /
Date of download: 6/2/2016 From: Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med. 2015;162(2):109-122.

Date of download: 6/2/2016 From: Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med. 2015;162(2):
Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.

Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.
Date of download: 6/3/2016 From: Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis Ann Intern Med. 2010;152(11):697-703. doi:10.7326/0003-4819-152-11-201006010-00002.

Date of download: 6/3/2016 From: Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis Ann Intern Med. 2010;152(11): doi: /
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.

Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Date of download: 6/3/2016 From: The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease:

Date of download: 6/3/2016 From: The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease:
Date of download: 6/3/2016 From: Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.

Date of download: 6/3/2016 From: Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
Date of download: 6/6/2016 From: Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review Ann Intern Med. 2011;155(4):234-245.

Date of download: 6/6/2016 From: Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review Ann Intern Med. 2011;155(4):
Date of download: 6/9/2016 From: Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications:

Date of download: 6/9/2016 From: Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications:
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11):746-757. doi:10.7326/0003-4819-159-11-201312030-00007.

Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/21/2016 From: Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice.

Date of download: 6/21/2016 From: Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice.
Date of download: 6/21/2016 From: Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services.

Date of download: 6/21/2016 From: Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services.

Similar presentations

Ads by Google